Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 8 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Serotonin Syndrome 1 Carcinoid Heart Disease 1

Interventions

Radiotherapy 302 Cisplatin 266 Cyclophosphamide 230 Doxorubicin 177 Paclitaxel 171 Vincristine 162 Carboplatin 153 Filgrastim 140 Etoposide 139 Gemcitabine 118 Docetaxel 114 Fluorouracil 113 Methotrexate 106 Dexamethasone 106 Cytarabine 106 Prednisone 92 Leucovorin 90 Gene Expression Profiling 82 Granulocyte Colony-Stimulating Factor 75 Specimen Handling 71 Magnetic Resonance Spectroscopy 64 Irinotecan 59 Capecitabine 59 Radiation 54 Polymerase Chain Reaction 51 Ifosfamide 51 Rituximab 49 Immunohistochemistry 49 Daunorubicin 49 Oxaliplatin 48

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × telotristat ethyl × Clear all

NCT04065165 2020-02-05

TELEFIRST

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn

Carcinoid Heart Disease, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡